Antibiotic resistance bacteria strains are a serious problem to the human population. The antibiotic drugs’ discovery in 1928 was a revolution in the entire healthcare industry. Their production and use increased rapidly over the years. But, their excessive consumption has affected their effectiveness in fighting bacteria. In fact, the World Health Organization reports that overconsumption of these drugs has been catastrophic. That’s because it has led to the evolution of common bacteria and emergence of resistant strains. It is claimed that about 2 million Americans suffer from antibiotic-resistant bacterial infections. And, a minimum of 23,000 of the victims succumbed to these infections. Fortunately, nature has an answer to this problem.
CBD for Antibiotic Resistance
Italian and British researchers have established that CBD has a built-in capacity to attack and kill drug-resistant bacteria. It is, therefore, an effective therapeutic aid for antibiotic resistance bacterial infections. The effectiveness of CBD has been tested using a minimum of 6 such bacteria and it has been proven effective. In fact, CBD is highly effective in fighting antibiotic-resistant bacteria than other drugs that are currently available.
How Cannabidiol Works
CBD is a promising therapeutic aid for antibiotic resistance bacterial infection because it has been proven effective in fighting these bacteria than other antibiotics available. Scientists say that this can be attributed to the anti-microbial and anti-inflammatory properties of CBD. These properties make CBD beneficial for the therapeutic aid of numerous conditions.
Researchers have further noted that CBD is more effective when applied topically to the affected areas. This implies that CBD can be used to develop potent antibiotics that are cost-effective in improving the symptoms of infections that fail to respond to the currently available antibiotics. CBD can also be an affordable therapeutic aid for antibiotic-resistant bacterial infections.
The Challenge We Face With CBD
Despite these findings, there is a major stumbling block to the implementation of the widespread use of CBD as a therapeutic aid for antibiotic resistant bacterial infections. That’s the current legality of cannabis. Though some states have legalized the use of cannabis for recreational and medical purposes, it remains a Schedule I substance federally. That means it is not considered to have any medical value and this hinders extensive research and development of drugs using CBD.
Nevertheless, you can buy CBD products and use them to treat antibiotic resistance infections. Such products include CBD oil, CBD wax, and CBD drip. Explore these products on this website to make a more informed buying decision.